Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Biomedica ; 39(Supl. 2): 26-31, 2019 08 01.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-31529831

RESUMO

Patients with lepromatous leprosy that have received treatment for many years usually get follow up biopsies for persistent skin lesions or positive bacilloscopy even if the values are lower than in the initial bacilloscopy. We report the case of a 48-year old woman with long-standing lepromatous leprosy of 15 years of evolution, with a bacterial index of 4 in the direct smear and the initial skin biopsy. The patient was treated with multidrug therapy for 32 months although the treatment recommended by the World Health Organization (WHO) is only for 12 months. A skin biopsy was taken to determine if there was an active disease. We observed a diffuse dermal inflammation with numerous foreign body giant cells and vacuolated macrophages (Virchow´s cells). These cells contained granular acid-fast material that was also positive with immunohistochemistry for BCG. There were fragmented bacilli and the BI was 2. These cells were also strongly positive for CD68. The biopsy was interpreted as a residual form of lepromatous leprosy that did not require further multidrug therapy. We have observed similar histological profiles in several cases. The lack of clinical data makes it a histological challenge. The accumulation of lipids in these giant cells is due to bacillary destruction and fusion of vacuolated macrophages. We discuss here the role of bacillary and host lipids in the pathogenesis of lepromatous leprosy. We concluded that there was no need to extend the 12-month multidrug therapy recommended by WHO.


Los pacientes con lepra lepromatosa (LL) que han recibido tratamiento durante años, usualmente tienen seguimiento con biopsias de piel para lesiones persistentes o con baciloscopia positiva, con valores menores a los iniciales. Presentamos una mujer de 48 años con LL de 15 años de evolución, con índice bacilar (IB) 4 en el extendido directo y en la biopsia, que recibió terapia multidroga durante 32 meses, aunque el tratamiento recomendado por la Organización mundial de la salud (OMS) es de 12 meses. Se tomó una biopsia de piel para determinar si la enfermedad estaba activa. Se observó inflamación dérmica difusa con numerosas células gigantes tipo cuerpo extraño y macrófagos vacuolados (células de Virchow). Estas células, CD68 positivas, contenían material granular ácido-alcohol resistente, positivo con inmunohistoquímica para BCG. Se encontraron bacilos fragmentados y el IB fue de 2. Se interpretó como una forma residual de LL y que la paciente no requería MDT adicional. Este perfil histológico lo hemos observado en casos similares. Sin datos clínicos estas biopsias son un reto diagnóstico. La acumulación de lípidos en estas células gigantes se debe a la destrucción bacilar y a la fusión de macrófagos vacuolados. Revisamos el papel de los lípidos del bacilo y del huésped en la patogénesis de la LL. En estos casos no es necesario extender los 12 meses de MDT recomendados por la OMS. En el seguimiento de los pacientes se recomienda contar con los hallazgos clínicos, la baciloscopia, la biopsia anual de piel y los títulos IgM anti-glicolípido fenólico.


Assuntos
Células Espumosas/patologia , Células Gigantes de Corpo Estranho/patologia , Hanseníase Virchowiana/patologia , Pele/patologia , Antígenos CD/análise , Antígenos de Diferenciação Mielomonocítica/análise , Biópsia , Parede Celular/química , Quimioterapia Combinada , Feminino , Células Espumosas/química , Células Espumosas/microbiologia , Células Gigantes de Corpo Estranho/química , Células Gigantes de Corpo Estranho/microbiologia , Interações Hospedeiro-Patógeno , Humanos , Hansenostáticos/uso terapêutico , Hanseníase Virchowiana/tratamento farmacológico , Lipídeos/análise , Pessoa de Meia-Idade , Mycobacterium leprae/química , Mycobacterium leprae/isolamento & purificação , Pele/microbiologia , Vacúolos
2.
Biomédica (Bogotá) ; 39(supl.2): 26-31, ago. 2019. graf
Artigo em Espanhol | LILACS | ID: biblio-1038825

RESUMO

Resumen Los pacientes con lepra lepromatosa que han recibido tratamiento durante años, usualmente requieren seguimiento con biopsias de piel para detectar lesiones persistentes o si la baciloscopia es positiva, incluso si los valores son menores que los iniciales. Se presenta el caso de una mujer de 48 años de edad con lepra lepromatosa de 15 años de evolución, índice bacilar de 4 en el extendido directo y en la biopsia, que recibió tratamiento con múltiples medicamentos durante 32 meses, aunque lo recomendado por la Organización Mundial de la Salud (OMS) es una duración de 12 meses. Se tomó una biopsia de piel para determinar si la enfermedad estaba activa. Se observó inflamación dérmica difusa con numerosas células gigantes de tipo cuerpo extraño y macrófagos vacuolados (células de Virchow). Estas células, CD68 positivas, contenían material granular ácido-alcohol resistente positivo con inmunohistoquímica para BCG. Se encontraron bacilos fragmentados y el índice bacilar fue de 2. Se interpretó como una forma residual de lepra lepromatosa y se concluyó que la paciente no requería prolongar el tratamiento con múltiples medicamentos. Este perfil histológico se ha observado en casos similares, pero sin datos clínicos estas biopsias representan un reto diagnóstico. La acumulación de lípidos en estas células gigantes se debe a la destrucción bacilar y a la fusión de macrófagos vacuolados. Se revisó el papel de los lípidos del bacilo y del huésped en la patogenia de la lepra lepromatosa. En estos casos, no es necesario extender los 12 meses de tratamiento con múltiples medicamentos recomendados por la OMS. En el seguimiento de los pacientes, se recomienda contar con los hallazgos clínicos, la baciloscopia, la biopsia anual de piel y los títulos IgM antiglucolípido fenólico.


Abstract Patients with lepromatous leprosy that have received treatment for many years usually get follow up biopsies for persistent skin lesions or positive bacilloscopy even if the values are lower than in the initial bacilloscopy. We report the case of a 48-year old woman with long-standing lepromatous leprosy of 15 years of evolution, with a bacterial index of 4 in the direct smear and the initial skin biopsy. The patient was treated with multidrug therapy for 32 months although the treatment recommended by the World Health Organization (WHO) is only for 12 months. A skin biopsy was taken to determine if there was an active disease. We observed a diffuse dermal inflammation with numerous foreign body giant cells and vacuolated macrophages (Virchow´s cells). These cells contained granular acid-fast material that was also positive with immunohistochemistry for BCG. There were fragmented bacilli and the BI was 2. These cells were also strongly positive for CD68. The biopsy was interpreted as a residual form of lepromatous leprosy that did not require further multidrug therapy. We have observed similar histological profiles in several cases. The lack of clinical data makes it a histological challenge. The accumulation of lipids in these giant cells is due to bacillary destruction and fusion of vacuolated macrophages. We discuss here the role of bacillary and host lipids in the pathogenesis of lepromatous leprosy. We concluded that there was no need to extend the 12-month multidrug therapy recommended by WHO. Clinical findings, bacilloscopy, annual skin biopsy, and anti-phenolic glycolipid-I IgM titers are recommended procedures for the follow-up of these patients.


Assuntos
Feminino , Humanos , Pessoa de Meia-Idade , Pele/patologia , Hanseníase Virchowiana/patologia , Células Gigantes de Corpo Estranho/patologia , Células Espumosas/patologia , Pele/microbiologia , Vacúolos , Biópsia , Antígenos de Diferenciação Mielomonocítica/análise , Hanseníase Virchowiana/tratamento farmacológico , Antígenos CD/análise , Células Gigantes de Corpo Estranho/microbiologia , Células Gigantes de Corpo Estranho/química , Parede Celular/química , Quimioterapia Combinada , Interações Hospedeiro-Patógeno , Células Espumosas/microbiologia , Células Espumosas/química , Hansenostáticos/uso terapêutico , Lipídeos/análise , Mycobacterium leprae/isolamento & purificação , Mycobacterium leprae/química
4.
Biomedica ; 32(1): 13-22, 2012.
Artigo em Espanhol | MEDLINE | ID: mdl-23235783

RESUMO

INTRODUCTION: Damage of testicles is frequent in lepromatous leprosy and worsened by the presence of erythema nodosum leprosum. Objective. A patient is presented who developed lepromatous leprosy and erythema nodosum leprosum with major testicular compromise. MATERIAL AND METHODS: The 28-year-old male patient had lepromatous leprosy since age 22. During a polychemotherapy treatment for the lepromatous leprosy, he presented chronic erythema nodosum leprosum that affected both testicles; he did not respond to the conventional treatment. A left orchidectomy was performed to treat the persistent pain. RESULTS: The extracted testis evidenced the following: tubular atrophy, extensive fibrosis, cumulus of foamy macrophages without rods, focal Leydig cell hyperplasia, linfocitary and granulomatous arteritis and endarteritis of small and medium size vessels. These changes were also observed in the epididymis. Two years after the polychemoterapy and the orchidectomy, the patient exhibited azoospermy, normal total testosterone, slightly diminished free testosterone and elevated levels of luteinizing hormone and follicle-stimulating hormone. No loss of libido or sexual activity was reported. General concepts of erythema nodosum leprosum were reviewed, as well as the pathologic changes produced by leprosy in the testis. CONCLUSION: Lepromatous leprosy may lead to hypogonadism. This condition is recommended for inclusion in leprosy diagnostic programs in order to detect and treat the consequences of the possible hypogonadism.


Assuntos
Eritema Nodoso/etiologia , Hipogonadismo/etiologia , Hanseníase Virchowiana/complicações , Doenças Testiculares/etiologia , Adulto , Atrofia , Azoospermia/etiologia , Clofazimina/uso terapêutico , Dapsona/uso terapêutico , Epididimo/patologia , Eritema Nodoso/patologia , Eritema Nodoso/cirurgia , Fibrose , Células Espumosas/patologia , Hormônio Foliculoestimulante/sangue , Humanos , Hiperplasia , Hipogonadismo/sangue , Hansenostáticos/uso terapêutico , Hanseníase Virchowiana/classificação , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/imunologia , Hanseníase Virchowiana/patologia , Células Intersticiais do Testículo/patologia , Hormônio Luteinizante/sangue , Masculino , Orquiectomia , Rifampina/uso terapêutico , Doenças Testiculares/patologia , Doenças Testiculares/cirurgia , Testosterona/sangue , Talidomida/uso terapêutico
5.
Biomédica (Bogotá) ; 32(1): 13-22, ene.-mar. 2012. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-639807

RESUMO

Introducción. La afección testicular es frecuente en la lepra lepromatosa, daño que se incrementa cuando cursa con eritema nudoso leproso. Objetivo. Presentar un paciente con lepra lepromatosa y eritema nudoso leproso con grave compromiso testicular. Materiales y métodos. Se estudió un hombre de 28 años con lepra lepromatosa desde los 22, que durante la poliquimioterapia para la lepra presentó eritema nudoso leproso crónico que afectó ambos testículos y no respondió al manejo convencional. El dolor persistente obligó a practicar orquidectomía izquierda. Resultados. Este testículo presentaba atrofia tubular y fibrosis notorias, conglomerados de macrófagos espumosos, sin bacilos, hiperplasia focal de células de Leydig, endarteritis y arteritis linfocitaria y granulomatosa de vasos pequeños y medianos; estos cambios también estaban presentes en el epidídimo. Un estudio llevado a cabo dos años después de terminar su tratamiento y de la orquidectomía izquierda, demostró azoospermia, testosterona total normal, testosterona libre discretamente disminuida y hormonas lutropina (luteinizante) y folitropina (estimulante del folículo) elevadas. No había disminución de la libido ni de su actividad sexual. Se revisaron los conceptos generales sobre el eritema nudoso leproso y las alteraciones que la lepra produce en el testículo. Conclusión. La lepra lepromatosa puede conducir a hipogonadismo. Los programas de lepra deben contemplar esta complicación para corregir y evitar sus secuelas.


Introduction. Damage of testicles is frequent in lepromatous leprosy and worsened by the presence of erythema nodosum leprosum. Objective. A patient is presented who developed lepromatous leprosy and erythema nodosum leprosum with major testicular compromise. Material and methods. The 28-year-old male patient had lepromatous leprosy since age 22. During a polychemotherapy treatment for the lepromatous leprosy, he presented chronic erythema nodosum leprosum that affected both testicles; he did not respond to the conventional treatment. A left orchidectomy was performed to treat the persistent pain. Results. The extracted testis evidenced the following: tubular atrophy, extensive fibrosis, cumulus of foamy macrophages without rods, focal Leydig cell hyperplasia, linfocitary and granulomatous arteritis and endarteritis of small and medium size vessels. These changes were also observed in the epididymis. Two years after the polychemoterapy and the orchidectomy, the patient exhibited azoospermy, normal total testosterone, slightly diminished free testosterone and elevated levels of luteinizing hormone and follicle-stimulating hormone. No loss of libido or sexual activity was reported. General concepts of erythema nodosum leprosum were reviewed, as well as the pathologic changes produced by leprosy in the testis. Conclusion. Lepromatous leprosy may lead to hypogonadism. This condition is recommended for inclusion in leprosy diagnostic programs in order to detect and treat the consequences of the possible hypogonadism.


Assuntos
Adulto , Humanos , Masculino , Eritema Nodoso/etiologia , Hipogonadismo/etiologia , Hanseníase Virchowiana/complicações , Doenças Testiculares/etiologia , Atrofia , Azoospermia/etiologia , Clofazimina/uso terapêutico , Dapsona/uso terapêutico , Epididimo/patologia , Eritema Nodoso/patologia , Eritema Nodoso/cirurgia , Fibrose , Células Espumosas/patologia , Hormônio Foliculoestimulante/sangue , Hiperplasia , Hipogonadismo/sangue , Hansenostáticos/uso terapêutico , Hanseníase Virchowiana/classificação , Hanseníase Virchowiana/tratamento farmacológico , Hanseníase Virchowiana/imunologia , Hanseníase Virchowiana/patologia , Células Intersticiais do Testículo/patologia , Hormônio Luteinizante/sangue , Orquiectomia , Rifampina/uso terapêutico , Doenças Testiculares/patologia , Doenças Testiculares/cirurgia , Testosterona/sangue , Talidomida/uso terapêutico
7.
s.l; s.n; 2003. 3 p. ilus.
Não convencional em Inglês | SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP | ID: biblio-1241183

RESUMO

Histoid leprosy is a distinct and rare form of multibacillary leprosy that presents clinically as well-demarcated cutaneous and subcutaneous nodules similar to dermatofibroma.....


Assuntos
Masculino , Humanos , Adulto , Biópsia por Agulha , Células Espumosas/patologia , Dermatopatias Bacterianas/patologia , Diagnóstico Diferencial , Hanseníase/patologia , Histiocitoma Fibroso Benigno/patologia , Mycobacterium leprae/citologia , Mycobacterium leprae/isolamento & purificação , Neoplasias Cutâneas/patologia
8.
J Am Acad Dermatol ; 32(2 Pt 2): 372-4, 1995 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-7829743

RESUMO

Clinical backgrounds of patients with adult-onset xanthogranuloma are somewhat different from those of patients with juvenile xanthogranuloma, but the histologic findings of both forms of the disease are identical. The lesions of the adult form are usually asymmetric. We describe a patient with adult-onset xanthogranuloma that appeared symmetrically on the ear lobes. This case suggests a possible role for mechanical stimuli (e.g., earrings) in the pathogenesis of adult-onset xanthogranuloma.


Assuntos
Orelha Externa/patologia , Granuloma/patologia , Xantomatose/patologia , Diagnóstico Diferencial , Otopatias/patologia , Feminino , Células Espumosas/patologia , Células Gigantes , Humanos , Hanseníase Virchowiana/patologia , Pessoa de Meia-Idade , Vacúolos/ultraestrutura , Xantogranuloma Juvenil/patologia
9.
Nippon Ganka Gakkai Zasshi ; 98(8): 801-6, 1994 Aug.
Artigo em Japonês | MEDLINE | ID: mdl-7942345

RESUMO

Eyes from autopsy cases of leprosy patients (29 eyes from 16 cases) were examined histologically. In some cases immunohistochemical methods were used. In the lepromatous type, ocular complications such as keratitis and iridocyclitis were often found. In the tuberculoid type, such complications were seldom encountered. In the active stage, lepra cells and "foamy cells" showed positive reaction to acid-fast staining and anti-BCG antibody but in the silent stage they did not react. All foamy cells in both the active and the silent stage showed positive reaction to KP1, but they did not react to lysozyme or alpha 1-antitrypsin. These results suggest that the foamy cells originated from macrophages, but that their biological activity was low.


Assuntos
Oftalmopatias/patologia , Hanseníase/complicações , Idoso , Idoso de 80 Anos ou mais , Anticorpos Antibacterianos/análise , Oftalmopatias/metabolismo , Feminino , Células Espumosas/metabolismo , Células Espumosas/patologia , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Mycobacterium bovis/imunologia
10.
Lepr India ; 55(3): 495-9, 1983 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-6656207

RESUMO

Twenty-five patients of leprosy classified according to the criteria of Ridley and Jopling (1966) were studied to verify the existence of isopathic phenomenon, using lepromin and autoclaved BCG as antigens. BCG as well as lepromin injection sites showed tuberculoid granulomas in all the cases of tuberculoid, borderline tuberculoid, mid-borderline and indeterminate leprosy. In lepromatous and borderline lepromatous cases BCG injection sites showed infiltration of foam cells containing AFB and foci of epithelioid cells, while lepromin injection sites showed infiltration of foam cells containing AFB only. These findings in the present study do not support the occurrence of isopathic phenomenon in leprosy with BCG.


Assuntos
Vacina BCG/farmacologia , Antígeno de Mitsuda/farmacologia , Hanseníase/imunologia , Células Espumosas/patologia , Humanos , Hanseníase/classificação , Hanseníase/patologia , Linfócitos/patologia , Testes Cutâneos , Tuberculoma/imunologia , Tuberculoma/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA